Standard name |
MIKI_COEXPRESSED_WITH_CYP19A1 |
Systematic name |
M1868 |
Brief description |
Nuclear receptors whose expression correlated with that of aromatase (CYP19A1) [GeneID=1588] in a panel of breast cancer biopsies. |
Full description or abstract |
Aromatase is a key enzyme in intratumoral estrogen production required for the production of estrogens through the conversion of serum androgens in postmenopausal breast cancer patients. There have been, however, controversies regarding the intratumoral localization of aromatase in human breast carcinoma tissues. Therefore, we have first examined the intratumoral localization of aromatase mRNA/protein in 19 breast carcinomas using laser capture microdissection/quantitative reverse transcription-PCR (RT-PCR) and immunohistochemistry. Aromatase mRNA and protein were detected in both intratumoral stromal and parenchymal cells in breast carcinoma tissues. Subsequent microarray expression profiling and clustering analyses, in addition to quantitative RT-PCR studies, showed a significant positive correlation between aromatase and estrogen-related receptor alpha mRNA expression in isolated carcinoma cells. We further examined an interaction between stromal cells isolated from human breast carcinoma tissues and breast carcinoma cell lines using a coculture system to study the biological characteristic of aromatase expression in carcinoma cells. Aromatase mRNA and enzyme activity and 17beta-hydroxysteroid dehydrogenase type 1 mRNA in breast carcinoma cell lines, including MCF-7 and SK-BR-3 cells, were up-regulated in the presence of patient-derived 32N or 74T intratumoral stromal cells. The results from steroid conversion assays were also consistent with the findings above. The results of our study also showed that aromatase inhibitors were more effective in inhibiting aromatization induced by coculture in MCF-7 than that in stromal 32N. The examination of the localization of aromatase and its regulation, including the interactions existing between different cell types in human breast carcinoma tissues, may provide important information as to achieving better clinical response to aromatase inhibitors in breast cancer patients. |
Collection |
C2: Curated CGP: Chemical and Genetic Perturbations |
Source publication |
Pubmed 17440110 Authors: Miki Y,Suzuki T,Tazawa C,Yamaguchi Y,Kitada K,Honma S,Moriya T,Hirakawa H,Evans DB,Hayashi S,Ohuchi N,Sasano H |
Exact source |
Fig 2B |
Related gene sets |
(show 6 gene sets from the same authors)
|
External links |
|
Filtered by similarity ?
|
|
Source species |
Homo sapiens |
Contributed by |
Jessica Robertson (MSigDB Team) |
Source platform or identifier namespace |
HUMAN_GENE_SYMBOL |
Dataset references |
|
Download gene set |
format: grp | gmt | xml | json | TSV metadata |
Compute overlaps ? |
(show collections to investigate for overlap with this gene set)
|
Compendia expression profiles ? |
NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Legacy heatmaps (PNG)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
|
Advanced query |
Further investigate
these 7 genes
|
Gene families ? |
Categorize these
7 genes by gene family
|
Show members |
(show 7 source identifiers mapped to 7 genes)
Source Id |
NCBI (Entrez) Gene Id |
Gene Symbol |
Gene Description |
NR1A1 |
7067 |
THRA |
thyroid hormone receptor alpha [Source:HGNC Sym... |
NR1I1 |
7421 |
VDR |
vitamin D receptor [Source:HGNC Symbol;Acc:HGNC... |
NR2A1 |
3172 |
HNF4A |
hepatocyte nuclear factor 4 alpha [Source:HGNC ... |
NR2C2 |
7182 |
NR2C2 |
nuclear receptor subfamily 2 group C member 2 [... |
NR2E3 |
10002 |
NR2E3 |
nuclear receptor subfamily 2 group E member 3 [... |
NR3B1 |
2101 |
ESRRA |
estrogen related receptor alpha [Source:HGNC Sy... |
NR6A1 |
2649 |
NR6A1 |
nuclear receptor subfamily 6 group A member 1 [... |
|
Version history |
3.1: First introduced
|